Cleveland Diagnostics
Latest round
- Series D
Last raised
- Feb 2021
Total raised
- $17M
Investors
- 2
About Cleveland Diagnostics
Founded in 2013 and based in Ohio, US, Cleveland Diagnostics, Inc. offers testing solutions for early detection of cancer and other high-grade disease. As of 2024, the company is headed by its CEO Arnon Chait. The product of Cleveland Diagnostics is the IsoPSA® test. This test is designed to offer a precise assessment of prostate cancer risk compared to traditional PSA tests. The test provides insights into the presence of aggressive cancer, thereby improving patient management and treatment decisions.
Who invested in Cleveland Diagnostics
2 investors across 1 round
See all investors in Cleveland Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Feb 9, 2021
Amount
$17M
Investors
Questions about Cleveland Diagnostics
Who invested in Cleveland Diagnostics?
Cleveland Diagnostics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cleveland Diagnostics raised?
Cleveland Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cleveland Diagnostics last raise money?
Cleveland Diagnostics's most recent round on record is a Series D, in Feb 2021.
What does Cleveland Diagnostics do?
Founded in 2013 and based in Ohio, US, Cleveland Diagnostics, Inc.
Where is Cleveland Diagnostics headquartered?
Cleveland Diagnostics is headquartered in Cleveland, US.
Which VCs invest in companies like Cleveland Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cleveland Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Cleveland Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.